Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Even Low-Dose X-rays Increase Cancer Risk

By HospiMedica staff writers
Posted on 14 Nov 2005
Exposure to x-rays and gamma rays, even at low-dose levels, increases cancer risk, according to new findings of a wide-ranging five-year study by a U.S. More...
National Research Council (NRC, Washington, DC, USA).

"There appears to be no threshold below which exposure can be viewed as harmless,” said Dr. Herbert L. Abrams, professor emeritus of radiology at Stanford University (CA, USA) and Harvard University (Boston, MA, USA) and a member in residence at the Center for International Security and Cooperation (CISAC, Stanford, CA, USA) in the Freeman Spogli Institute for International Studies. Dr. Abrams was one of two physicians and the only member from Stanford on the committee of 16 international experts in fields including genetics, epidemiology, radiation biology, cancer biology, radiology, and physics.

The landmark 700-page advisory report to the U.S. government, titled "Biological Effects of Ionizing Radiation (BEIR) VII,” was completed in July 2004, close to the eve of the 60-year anniversary of the Hiroshima and Nagasaki bombings. Beginning with the first BEIR study, published in 1956, the reports have used information from the Life Span Study by the Radiation Effects Research Foundation in Japan, which continues to follow developments among a cohort of 120,000 people who were in Hiroshima or Nagasaki at the time of the bombings, as well as other radiation-exposure studies.

The new report corroborates that even very low doses of radiation can produce cellular injury. The committee defined "low-dose” as a range from near zero up to approximately 100 milliSievert--about 10 times that from a computed tomography (CT) scan, 1,000 times greater than a mammogram, and 30-40 times the annual background exposure a person encounters.

The key findings of the report included that for boys, radiation exposure in the first year of life generates three to four times the lifetime cancer risk as exposure to the same dose between the ages of 20 and 50. Female infants have nearly twice the risk as male infants. For women, the risks of developing cancer after exposure to radiation were 37.5% higher than for men. The risks for all solid tumors, such as lung and breast tumors, when combined, were nearly 50% greater for women than for men.





Related Links:
U.S. National Research Council
Stanford University

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.